Literature DB >> 1859940

The impact of HIV infection on the global epidemiology of tuberculosis.

K Styblo1.   

Abstract

HIV is the strongest risk factor for tuberculous disease observed in the last 100 years in subjects infected with tubercle bacilli. Its impact upon tuberculosis incidence is so great that it has disrupted the balance between the tubercle bacillus and the community. The breakdown rate from tuberculous infection to active tuberculosis in persons infected dually is at least 30%. Although adequate chemoprophylaxis would prevent a considerable number of tuberculosis cases among these individuals, its application is not feasible in developing countries with a high prevalence of both tuberculous and HIV infections. Thus it seems that very little can be done against the increase in the incidence of tuberculosis caused by HIV. The only feasible measure to contain the transmission of tuberculous infection is to achieve a high cure rate and a high detection rate of smear-positive and other cases. This would enable us to contain-to an extent-the transmission of tuberculous infection. The results of IUATLD assisted National Tuberculosis Programmes in Tanzania and Malawi show that this can be achieved.

Entities:  

Mesh:

Year:  1991        PMID: 1859940

Source DB:  PubMed          Journal:  Bull Int Union Tuberc Lung Dis        ISSN: 1011-789X


  10 in total

1.  Epidemiology of Respiratory Disease in Malawi.

Authors:  Stephen Gordon; Stephen Graham
Journal:  Malawi Med J       Date:  2006-09       Impact factor: 0.875

2.  Prevention and early detection of tuberculosis.

Authors:  M Hortoneda; C Saiz; J I Alfonso; P Cortina; J I Gonzalez; A Sabater
Journal:  Eur J Epidemiol       Date:  1996-08       Impact factor: 8.082

Review 3.  Tropical respiratory medicine. 2. Impact of human immunodeficiency virus on tuberculosis in developing countries.

Authors:  P P Nunn; A M Elliott; K P McAdam
Journal:  Thorax       Date:  1994-05       Impact factor: 9.139

4.  Evaluation of a bacteriophage-based assay (phage amplified biologically assay) as a rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide, and ciprofloxacin among clinical isolates of Mycobacterium tuberculosis.

Authors:  I J Eltringham; S M Wilson; F A Drobniewski
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

5.  Towards elimination of tuberculosis in a low income country: the experience of Cuba, 1962-97.

Authors:  A Marrero; J A Caminero; R Rodríguez; N E Billo
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

6.  Ocular disease in patients with tuberculosis and HIV presenting with fever in Africa.

Authors:  N A V Beare; J G Kublin; D K Lewis; M J Schijffelen; R P H Peters; G Joaki; J Kumwenda; E E Zijlstra
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

7.  Secular trends of tuberculosis in western Europe.

Authors:  M C Raviglione; P Sudre; H L Rieder; S Spinaci; A Kochi
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

8.  Global tuberculosis incidence and mortality during 1990-2000.

Authors:  P J Dolin; M C Raviglione; A Kochi
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

9.  Tuberculosis in Cape Town: An age-structured transmission model.

Authors:  Nello Blaser; Cindy Zahnd; Sabine Hermans; Luisa Salazar-Vizcaya; Janne Estill; Carl Morrow; Matthias Egger; Olivia Keiser; Robin Wood
Journal:  Epidemics       Date:  2015-10-20       Impact factor: 4.396

10.  In vitro and in vivo activities of the benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis.

Authors:  T Hirata; H Saito; H Tomioka; K Sato; J Jidoi; K Hosoe; T Hidaka
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.